Younger highly myopic patients have a higher risk of being steroid responders

Article

Younger patients with high myopia are at more risk of a postoperative steroid response after uneventful cataract surgery, according to an investigation published in the Journal of Cataract and Refractive Surgery.

Younger patients with high myopia are at more risk of a postoperative steroid response after uneventful cataract surgery, according to an investigation published in the Journal of Cataract and Refractive Surgery.

Dr David F. Chang et al., Los Altos, California, USA, conducted a case-control, retrospective chart review on 1642 patients who underwent uneventful cataract surgery. Patients were administered topical prednisolone acetate 1.0% postoperatively.

Ocular axial length (AL), patient age and intraocular pressure (IOP) were preoperatively recorded, 1-day postoperatively and at least once in the initial postoperative month. During this time the patients received a topical corticosteroid agent.

If the patients experienced an increase in IOP of more than 25% while receiving topical prednisolone, and this reduced by more than 25% once treatment had ceased, then they were considered to be steroid responders. The age and AL of those patients who had a steroid response and those who didn't were compared for analysis.

Out of 1642 patients, 39 were diagnosed as steroid responders. It was concluded that younger age and longer AL were linked with high steroid response risk. The results suggest steroid responders may require more IOP monitoring or topical anti-inflammatory medications.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.